Awareness of human papillomavirus, cervical cancer and its prevention among primigravid antenatal clinic attendees in a tertiary care hospital in Sri Lanka

A cross-sectional study

Aruni H.W. De Silva, Nirma Samarawickrema, Anuradhani Kasturiratne, S. Rachel Skinner, Ananda Rajitha Wickremasinghe, Suzanne M. Garland

Research output: Contribution to journalArticleResearchpeer-review

Abstract

Background: Cervical cancer is the second commonest cancer amongst Sri Lankan women. With introduction of the human papillomavirus (HPV) vaccine to the national immunisation schedule, awareness and prevention of disease underpins vaccine uptake. Knowledge of HPV, HPV-related diseases and attitudes towards prevention and screening among urban women was assessed. Methods: Primigravids attending Colombo North Teaching Hospital antenatal clinics were recruited over 8 months as surrogates for women who have recently become sexually active. Data through a self-administered questionnaire on three domains were collected (cervical cancer, Pap testing, HPV and vaccine). Results: Of 667 participants (mean age 23.9 (s.d. = 4.4) years, 68.0% (n = 454) had >11 years of schooling), only 1.5% (n = 10) were aware of all three domains: 55.0% (370/667) had heard of cervical cancer, 19.0% of whom (70/370) knew it was sexually acquired, 9.0% (60/667) were aware of Pap screening, while 5.4% (36/665) had heard about HPV and <1.0% (5/667) knew it caused cancer. The total knowledge score ranged from zero (379/665) to nine (2/665), with a mean of 0.9 (s.d.-1.4), with awareness increasing with level of education (χ2 = 18.6 P <0.001). Of those aware of Pap testing, 8.0% (5/60) were reluctant to undergo testing, while 46.6% (28/60) had no apprehension. Conclusions: Knowledge of cervical cancer, Pap testing, HPV and vaccine was low, especially in terms of HPV. Among those aware of Pap screening, generally there were favourable attitudes to having a test. These data have implications for acceptance of the vaccine and any future expansion of cervical screening with newer, more cost-effective technologies.

Original languageEnglish
Pages (from-to)212-217
Number of pages6
JournalSexual Health
Volume16
Issue number3
DOIs
Publication statusPublished - 15 May 2019

Keywords

  • Pap test
  • screening
  • South Asia
  • vaccine
  • women

Cite this

De Silva, Aruni H.W. ; Samarawickrema, Nirma ; Kasturiratne, Anuradhani ; Skinner, S. Rachel ; Wickremasinghe, Ananda Rajitha ; Garland, Suzanne M. / Awareness of human papillomavirus, cervical cancer and its prevention among primigravid antenatal clinic attendees in a tertiary care hospital in Sri Lanka : A cross-sectional study. In: Sexual Health. 2019 ; Vol. 16, No. 3. pp. 212-217.
@article{996f4a398cbd4b499965603379d47475,
title = "Awareness of human papillomavirus, cervical cancer and its prevention among primigravid antenatal clinic attendees in a tertiary care hospital in Sri Lanka: A cross-sectional study",
abstract = "Background: Cervical cancer is the second commonest cancer amongst Sri Lankan women. With introduction of the human papillomavirus (HPV) vaccine to the national immunisation schedule, awareness and prevention of disease underpins vaccine uptake. Knowledge of HPV, HPV-related diseases and attitudes towards prevention and screening among urban women was assessed. Methods: Primigravids attending Colombo North Teaching Hospital antenatal clinics were recruited over 8 months as surrogates for women who have recently become sexually active. Data through a self-administered questionnaire on three domains were collected (cervical cancer, Pap testing, HPV and vaccine). Results: Of 667 participants (mean age 23.9 (s.d. = 4.4) years, 68.0{\%} (n = 454) had >11 years of schooling), only 1.5{\%} (n = 10) were aware of all three domains: 55.0{\%} (370/667) had heard of cervical cancer, 19.0{\%} of whom (70/370) knew it was sexually acquired, 9.0{\%} (60/667) were aware of Pap screening, while 5.4{\%} (36/665) had heard about HPV and <1.0{\%} (5/667) knew it caused cancer. The total knowledge score ranged from zero (379/665) to nine (2/665), with a mean of 0.9 (s.d.-1.4), with awareness increasing with level of education (χ2 = 18.6 P <0.001). Of those aware of Pap testing, 8.0{\%} (5/60) were reluctant to undergo testing, while 46.6{\%} (28/60) had no apprehension. Conclusions: Knowledge of cervical cancer, Pap testing, HPV and vaccine was low, especially in terms of HPV. Among those aware of Pap screening, generally there were favourable attitudes to having a test. These data have implications for acceptance of the vaccine and any future expansion of cervical screening with newer, more cost-effective technologies.",
keywords = "Pap test, screening, South Asia, vaccine, women",
author = "{De Silva}, {Aruni H.W.} and Nirma Samarawickrema and Anuradhani Kasturiratne and Skinner, {S. Rachel} and Wickremasinghe, {Ananda Rajitha} and Garland, {Suzanne M.}",
year = "2019",
month = "5",
day = "15",
doi = "10.1071/SH18080",
language = "English",
volume = "16",
pages = "212--217",
journal = "Sexual Health",
issn = "1448-5028",
publisher = "CSIRO",
number = "3",

}

Awareness of human papillomavirus, cervical cancer and its prevention among primigravid antenatal clinic attendees in a tertiary care hospital in Sri Lanka : A cross-sectional study. / De Silva, Aruni H.W.; Samarawickrema, Nirma; Kasturiratne, Anuradhani; Skinner, S. Rachel; Wickremasinghe, Ananda Rajitha; Garland, Suzanne M.

In: Sexual Health, Vol. 16, No. 3, 15.05.2019, p. 212-217.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - Awareness of human papillomavirus, cervical cancer and its prevention among primigravid antenatal clinic attendees in a tertiary care hospital in Sri Lanka

T2 - A cross-sectional study

AU - De Silva, Aruni H.W.

AU - Samarawickrema, Nirma

AU - Kasturiratne, Anuradhani

AU - Skinner, S. Rachel

AU - Wickremasinghe, Ananda Rajitha

AU - Garland, Suzanne M.

PY - 2019/5/15

Y1 - 2019/5/15

N2 - Background: Cervical cancer is the second commonest cancer amongst Sri Lankan women. With introduction of the human papillomavirus (HPV) vaccine to the national immunisation schedule, awareness and prevention of disease underpins vaccine uptake. Knowledge of HPV, HPV-related diseases and attitudes towards prevention and screening among urban women was assessed. Methods: Primigravids attending Colombo North Teaching Hospital antenatal clinics were recruited over 8 months as surrogates for women who have recently become sexually active. Data through a self-administered questionnaire on three domains were collected (cervical cancer, Pap testing, HPV and vaccine). Results: Of 667 participants (mean age 23.9 (s.d. = 4.4) years, 68.0% (n = 454) had >11 years of schooling), only 1.5% (n = 10) were aware of all three domains: 55.0% (370/667) had heard of cervical cancer, 19.0% of whom (70/370) knew it was sexually acquired, 9.0% (60/667) were aware of Pap screening, while 5.4% (36/665) had heard about HPV and <1.0% (5/667) knew it caused cancer. The total knowledge score ranged from zero (379/665) to nine (2/665), with a mean of 0.9 (s.d.-1.4), with awareness increasing with level of education (χ2 = 18.6 P <0.001). Of those aware of Pap testing, 8.0% (5/60) were reluctant to undergo testing, while 46.6% (28/60) had no apprehension. Conclusions: Knowledge of cervical cancer, Pap testing, HPV and vaccine was low, especially in terms of HPV. Among those aware of Pap screening, generally there were favourable attitudes to having a test. These data have implications for acceptance of the vaccine and any future expansion of cervical screening with newer, more cost-effective technologies.

AB - Background: Cervical cancer is the second commonest cancer amongst Sri Lankan women. With introduction of the human papillomavirus (HPV) vaccine to the national immunisation schedule, awareness and prevention of disease underpins vaccine uptake. Knowledge of HPV, HPV-related diseases and attitudes towards prevention and screening among urban women was assessed. Methods: Primigravids attending Colombo North Teaching Hospital antenatal clinics were recruited over 8 months as surrogates for women who have recently become sexually active. Data through a self-administered questionnaire on three domains were collected (cervical cancer, Pap testing, HPV and vaccine). Results: Of 667 participants (mean age 23.9 (s.d. = 4.4) years, 68.0% (n = 454) had >11 years of schooling), only 1.5% (n = 10) were aware of all three domains: 55.0% (370/667) had heard of cervical cancer, 19.0% of whom (70/370) knew it was sexually acquired, 9.0% (60/667) were aware of Pap screening, while 5.4% (36/665) had heard about HPV and <1.0% (5/667) knew it caused cancer. The total knowledge score ranged from zero (379/665) to nine (2/665), with a mean of 0.9 (s.d.-1.4), with awareness increasing with level of education (χ2 = 18.6 P <0.001). Of those aware of Pap testing, 8.0% (5/60) were reluctant to undergo testing, while 46.6% (28/60) had no apprehension. Conclusions: Knowledge of cervical cancer, Pap testing, HPV and vaccine was low, especially in terms of HPV. Among those aware of Pap screening, generally there were favourable attitudes to having a test. These data have implications for acceptance of the vaccine and any future expansion of cervical screening with newer, more cost-effective technologies.

KW - Pap test

KW - screening

KW - South Asia

KW - vaccine

KW - women

UR - http://www.scopus.com/inward/record.url?scp=85065963255&partnerID=8YFLogxK

U2 - 10.1071/SH18080

DO - 10.1071/SH18080

M3 - Article

VL - 16

SP - 212

EP - 217

JO - Sexual Health

JF - Sexual Health

SN - 1448-5028

IS - 3

ER -